Hello, Guest
Login
Sign Up
 
 

Investors Review: Sumitomo Mitsui Financial Grp, Oxygen Biotherapeutics, Atmel Corporation, Sequenom

 
 
Repost This

Dallas, TX -- (SBWIRE) -- 03/12/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Sumitomo Mitsui Financial Grp, Inc.(ADR) (NYSE:SMFG) shares jumped 5.60% to $8.68. The 52 week trading range for the company is $5.55 - $8.39. The company is engaged in the financial services-related business. The Banking segment is engaged in the deposit, loan, securities transaction, securities investment, domestic and foreign exchange, bond fiduciary and registration, trust, security investment trust and insurance over-the-counter sales business.

Is SMFG a Strong Buy After The Recent Gain? Let’s Find out Here

Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT) shares gained 5.38% and closed at $0.315. The company, on Mar. 11, announced the closing of a $2.1 million funding from an institutional investor. The company is in danger of having its stock delisted from NASDAQ.

Last year, Qxygen was notified on being delisted from the NASDAQ trading service because its price per share went below $1 and market capitalization fell below $35 million. A company has to fulfil both requirements to hold a listing with NASDAQ.

Is OXBT a Strong Buying Opportunity After The Recent Slump? Find out Here

Atmel Corporation (NASDAQ:ATML) shares gained 5.26% to $6.80. The company, on Mar. 7, announced that it has completed the acquisition of Integrated Device Technology's (NASDAQ: IDTI) smart metering IC product lines and technologies, further enhancing Atmel's smart energy product portfolio. Terms of the transaction were not disclosed.

Additionally, the company, on Feb. 26, announced its recently launched AT86RF233 2.4GHz IEEE 802.15.4 radio transceiver supports distance measurement between two radios, also known as ranging.

Should Investors Consider ATML After The Recent price Action? Get Free Trend Analysis Here

Sequenom, Inc. (NASDAQ:SQNM) shares jumped 5.10% to $4.53. The company, on Mar. 7, reported total revenues of $33.7 million and $89.7 million for the fourth quarter and full year of 2012, respectively. Net loss was $32.8 million, or $0.29 per share, and $117.1 million, or $1.03 per share, for the fourth quarter and full year, respectively.

Should Investors Consider SQNM After The Recent price Action? Get Free Trend Analysis Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.